Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Aristo Bio-Tech and Lifescience IPO.
September 17, 2024 12:38:00 PM
With a trio of biotechs hitting the Nasdaq on Friday, it was easy to miss a smaller-scale public debut from another clinical-stage drug developer on the other side of the ESMO weekend. | With a trio ...
Published by : FierceBiotechSeptember 13, 2024 11:39:33 PM
A trio of biotech companies� shares rose in their first trading sessions after they each sold more shares in their respective initial public offerings than they had planned.
Published by : Bloomberg on MSNAugust 30, 2024 10:36:00 AM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Published by : InvestingSeptember 13, 2024 2:16:00 PM
Two local biotech companies have held initial public offerings, doubling the number of IPOs at Massachusetts firms so far in 2024. Both will start trading Friday on the Nasdaq exchange.
Published by : The Business JournalsSeptember 12, 2024 3:29:00 AM
Early-stage biotech Zymeworks, which develops antibodies targeting HER2 tumours, announced terms of its potential IPO earlier this month. Based in Vancouver, Canada, and backed by Eli Lilly and ...
Published by : pharmaphorumSeptember 9, 2024 3:30:00 PM
MBX has fleshed out plans to take in over $136 million from its IPO as the biotech looks to bring a potential challenger to Ascendis Pharma�s rare endocrine disease drug Yorvipath into phase 3.
Published by : FierceBiotechSeptember 9, 2024 8:04:00 PM
Two Massachusetts life sciences companies are both ... to become the third and fourth Massachusetts biotech companies to go public in 2024. Both IPOs are expected to take place this week ...
Published by : The Business JournalsSeptember 11, 2024 3:30:00 AM
Weekend team, we have something both short and sweet for you: A dig into the Reddit IPO filing that came out just after we recorded our final, regular episode of the week. Since we could not wait ...
Published by : TechCrunchAugust 30, 2024 5:41:00 PM
Hello and welcome back to Equity, TechCrunch�s venture capital-focused podcast, where we unpack the numbers behind the headlines. We were a smaller team this week, with Natasha and Alex ...
Published by : TechCrunchSeptember 10, 2024 3:30:00 AM
Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...
Published by : Benzinga.comSeptember 8, 2024 3:30:00 AM
JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations. Please note that if you subscribe to one of ...
Published by : JD SupraSeptember 9, 2024 3:29:00 AM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Published by : MorningstarThe allotment status of Aristo Bio-Tech and Lifescience Limited IPO is now available online. The public issue of Aristo Bio-Tech and Lifescience IPO was open on Jan 16, 2023 and closed for subscription on Jan 19, 2023. The equity shares of the company to be list at NSE SME
.
The IPO Shares of Aristo Bio-Tech and Lifescience Limited IPO are proposed to list on Monday, January 30, 2023 at NSE SME. The public issue of Aristo Bio-Tech and Lifescience IPO was opened on Jan 16, 2023 and closed for subscription on Jan 19, 2023. Aristo Bio-Tech and Lifescience IPO Listing Date and Information:
| Listing Date | Monday, January 30, 2023 |
| BSE Script Code | |
| NSE Symbol | ARISTO |
| Listing In | |
| ISIN | INE082101010 |
| Issue Price | ₹72 Per Equity Share |
| Face Value | ₹10 Per Equity Share |
SME : Aristo Bio-Tech and Lifescience Limited is entering in the capital market with an IPO of 1,812,800 Equity Shares of Rs 10 aggregating up to Rs 13.05 Crore. The price for the issue has been set at Rs 72 Per Equity Share.
Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company. They are mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various Pesticides.
The issue opens on Jan 16, 2023 and closes for subscription on Jan 19, 2023. The equity shares of the company to be list at NSE SME.
SME: The issue of Aristo Bio-Tech and Lifescience Limited opens on Jan 16, 2023 and closes for subscription on Jan 19, 2023. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 72 Per Equity Share.
The Aristo Bio-Tech and Lifescience IPO is proposed to open on January 16, 2023. The IPO application ends on January 19, 2023.
Retail investors can apply in the retail or non-institutional investor category from January 16, 2023 to January 19, 2023. The Aristo Bio-Tech and Lifescience IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Aristo Bio-Tech and Lifescience IPO will open for subscription on January 16, 2023. The public issue will close on January 19, 2023.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
